Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Introduction As the transgender patient population continues to increase, urologists and
other providers who treat genitourinary malignancies will increasingly encounter cases of …

Methods for estimating heterogeneous treatment effect in observational data have largely
focused on continuous or binary outcomes, and have been relatively less vetted with …

Background Prostate cancer (PCa) has a profoundly immunosuppressive microenvironment
and is commonly immune excluded with few infiltrative lymphocytes and low levels of …

Background The optimal treatment for patients with high-risk prostate cancer (PCa) remains
a debate and selection of patients to receive proper therapy is still an unsettled question …

Objective.-The purpose of the guidelines national committee ccAFU was to propose updated
french guidelines for prostate cancer. Methods.-A Medline search was achieved between …

Context The optimum use of brachytherapy (BT) combined with external beam radiotherapy
(EBRT) for localised/locally advanced prostate cancer (PCa) remains uncertain. Objective …

Purpose This article aims to examine how users' involvement in value co-creation influences
the development and orchestration of well-being ecosystems to help tackle complex societal …

A previous study comparing external beam radiation therapy with/without brachytherapy
(EBRT±BT) and radical prostatectomy (RP) for high-risk localized prostate cancer (PCa) did …

High-risk prostate cancer is a heterogeneous disease that lacks clear consensus on its ideal
management. Historically, non-surgical treatment was the preferred strategy, and several …